Akbar, NoorSiddiqui, RuqaiyyahEl-Gamal, Mohammed I.Zaraei, Seyed-OmarAlawfi, Bader S.Khan, Naveed Ahmed2024-05-192024-05-1920230932-01131432-1955https://doi.org10.1007/s00436-023-07953-whttps://hdl.handle.net/20.500.12713/5393Naegleria fowleri is a free-living thermophilic flagellate amoeba that causes a rare but life-threatening infection called primary amoebic meningoencephalitis (PAM), with a very high fatality rate. Herein, the anti-amoebic potential of carboxamide derivatives possessing sulfonyl or sulfamoyl moiety was assessed against pathogenic N. fowleri using amoebicidal, cytotoxicity and cytopathogenicity assays. The results from amoebicidal experiments showed that derivatives dramatically reduced N. fowleri viability. Selected derivatives demonstrated IC50 values at lower concentrations; 1j showed IC50 at 24.65 mu M, while 1k inhibited 50% amoebae growth at 23.31 mu M. Compounds with significant amoebicidal effects demonstrated limited cytotoxicity against human cerebral microvascular endothelial cells. Finally, some derivatives mitigated N. fowleri-instigated host cell death. Ultimately, this study demonstrated that 1j and 1k exhibited potent anti-amoebic activity and ought to be looked at in future studies for the development of therapeutic anti-amoebic pharmaceuticals. Further investigation is required to determine the clinical relevance of our findings.eninfo:eu-repo/semantics/closedAccessNaegleria FowleriAmoebicidalCarboxamideSulfonylSulfamoylPrimary Amoebic MeningoencephalitisCytopathogenicityArticle122112539254837665414WOS:0010618991000012-s2.0-85169667312N/A10.1007/s00436-023-07953-wQ1